Experts see improvements with bypass liner in diabetes

02/1/2013 | Medscape (free registration)

Moderately obese type 2 diabetes patients who used a duodenal-jejunal bypass liner attained significant reductions in fasting plasma glucose and A1C levels and body weight at 52 weeks, a study in the Journal of Clinical Endocrinology and Metabolism indicated. Researchers also noted lower bad cholesterol and triglyceride rates in patients.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA